Lisa Suennen has spent over 35 years in healthcare and technology as a venture capitalist, entrepreneur, operating executive, and strategy consultant. She has worked broadly across healthcare and life sciences, especially where these sectors converge with technology.

Lisa serves as Managing Partner of American Heart Association Ventures, a platform of four venture funds investing across the full spectrum of healthcare services, health technology, and medical devices companies that prevent and address cardiovascular health, brain health and other conditions that directly and indirectly contribute to improving outcomes in the key focal areas of the American Heart Association’s Mission.

Lisa has held General Partner roles at several venture funds, including Manatt Ventures, Psilos Group, and GE Ventures, where she led the healthcare venture fund and sat on the overall GE Ventures Investment Committee. Lisa has also held executive-level operating roles at Canary Medical and Manatt, Phelps & Phillips and was a key management team member at Merit Behavioral Care (formerly American Biodyne), where she was instrumental in building the company from early stage to a large and highly profitable public company.  Lisa was also Co-founder and CEO of CSweetener, a company focused on matching mentors with rising healthcare leaders (sold to HLTH Foundation).

Lisa chairs the International Investment Committee of the Australian & Victorian government-funded ANDHealth Digital Health Fund, is past chair of the Scientific Advisory Board of the NASA -funded Translational Research Institute for Space Health and serves on the advisory boards of several emerging companies.  Lisa is a Fellow of the Aspen Institute’s Health Innovators Fellowship and on faculty at the UC Berkeley Haas School of Business where she teaches the annual class on healthcare innovation and investment.  Lisa writes the Venture Valkyrie blog and is an internationally recognized author and speaker.